Kenneth Krogulski - Apr 14, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Apr 14, 2022
Transactions value $
$2,791
Form type
4
Date filed
5/6/2022, 05:05 PM
Previous filing
Apr 29, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $255 +94 +0.05% $2.71 184K Apr 16, 2022 Direct F1
transaction CPIX Common Stock Purchase $247 +94 +0.05% $2.63 184K Apr 18, 2022 Direct F1
transaction CPIX Common Stock Purchase $253 +94 +0.05% $2.69 184K Apr 19, 2022 Direct F1
transaction CPIX Common Stock Purchase $258 +94 +0.05% $2.74 185K Apr 20, 2022 Direct F1
transaction CPIX Common Stock Purchase $259 +94 +0.05% $2.75 185K Apr 21, 2022 Direct F1
transaction CPIX Common Stock Purchase $257 +94 +0.05% $2.73 185K Apr 22, 2022 Direct F1
transaction CPIX Common Stock Purchase $265 +101 +0.05% $2.62 185K Apr 25, 2022 Direct F1
transaction CPIX Common Stock Purchase $256 +101 +0.05% $2.53 185K Apr 26, 2022 Direct F1
transaction CPIX Common Stock Purchase $243 +101 +0.05% $2.41 185K Apr 27, 2022 Direct F1
transaction CPIX Common Stock Purchase $254 +101 +0.05% $2.51 185K Apr 28, 2022 Direct F1
transaction CPIX Common Stock Purchase $246 +101 +0.05% $2.44 185K Apr 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.